Trial intelligence / Profile preview

Albumin-bound paclitaxel after first-line failure in elderly patients with advanced gastric cancer

ChiCTR1900026165Phase 4Recruiting

Sponsor
Affiliated Hospital of Qinghai University
Start
Oct 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of paclitaxel in gastric cancer (GC), sponsored by Affiliated Hospital of Qinghai University. Primary endpoints: CD4 lymphocyte counts in peripheral blood and CD8 lymphocyte counts in peripheral blood. Started Oct 2019; status: recruiting.

02

Drugs

paclitaxel
03

Conditions

gastric cancer (GC)

Beyond the preview

Go deeper on ChiCTR1900026165.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900026165.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call